2009, together with Tadamitsu Kishimoto and Toshio Hirano: Crafoord Prize in Polyarthritis for “for their pioneering work to isolate interleukins, determine their properties and explore their role in the onset of inflammatory diseases”.
He has developed anti-IL6 receptor therapy for several immune disorders including Castleman's disease, rheumatoid arthritis and juvenile idiopathic arthritis.
Interleukin 6 and its receptor were discovered and cloned at Osaka University, Japan, by Tadamitsu Kishimoto in the 1980s.
Tadamitsu Kishimoto | Masashi Kishimoto | Yoshihisa Kishimoto |